000			03661nam a22003498i 4500
001			CR9781107588738
003			UkCbUP
005			20200124160214.0
006			m|||||o||d||||||||
007			cr||||||||||||
008			131007s2015||||enk o ||1 0|eng|d
020			_a9781107588738 (ebook)
020			_z9781107066007 (hardback)
040			_aUkCbUP _beng _erda _cUkCbUP
050	0	0	_aRC376.5 _b.M44 2015
082	0	0	_a616.8/3 _223
245	0	0	_aMedication-induced movement disorders / _cedited by Joseph H. Friedman, Butler Hospital and Department of Neurology at the Alpert Medical School of Brown University, Providence, RI, and School of Pharmacy at the University of Rhode Island, Kingston, RI, USA.
264		1	_aCambridge : _bCambridge University Press, _c2015.
300			_a1 online resource (ix, 197 pages) : _bdigital, PDF file(s).
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
500			_aTitle from publisher's bibliographic system (viewed on 05 Oct 2015).
505	8		_aMachine generated contents note: List of contributors; Dedication; Introduction; 1. Acute akathisia Drew S. Kern and Anthony E. Lang; 2. Acute dystonia Anne Marthe Meppelink and Mark J. Edwards; 3. Neuroleptic malignant syndrome Atbin Djamashidian and Sean S. O'Sullivan; 4. Serotonin syndrome Dimitrios A. Nacopoulos and Hubert H. Fernandez; 5. Neuroleptic Parkinsonism Joseph H. Friedman; 6. Tardive syndromes Daniel Tarsy and Raminder Parihar; 7. Tardive dyskinesia treatment Tracy M. Jones, Israt Jahan and Theresa A. Zesiewicz; 8. Atypical antipsychotics and movement disorders Rob M. A. de Bie; 9. Restless legs syndrome Roongroj Bhidayasiri and Pattamon Panyakaew; 10. Medication-induced tremors Peter A. Lewitt; 11. L-Dopa dyskinesias Juan Ramirez-Castaneda and Joseph Jankovic; 12. VPA, lithium, amiodarone and other non-DA Michael Silver and Stewart A. Factor; 13. Anti-depressants and movement disorders Gilles Fe;nelon; 14. Ataxia Marina Sanchez Abraham and Oscar S. Gershanik; 15. Myoclonus and asterixis P. D. Thompson, T. J. Kleinig and T. E. Kimber; 16. Imaging in medication-induced Parkinsonism Danna Jennings; 17. Deep brain stimulation for Tardive disorders Bernardo Rodrigues and Kelvin L. Chou; Index.
520			_aMedications that may produce movement disorders are widely used. The resulting disorders are often highly disconcerting for the patient and their relatives, especially when the connection between medication and disorder is not recognized. However, ascribing an adverse drug effect to medication exposure is often difficult, especially when the side effect is rare. Covering various drugs - including the major classes of medications working primarily on the brain, specifically antipsychotics and antidepressants - this all-encompassing review of medication-induced movement disorders aids early recognition and improved treatment. The problem of what to do when the offending medication cannot be reduced is also reviewed. It discusses the best options for evaluation and treatment, including medical imaging and deep brain stimulation, and guides the clinician in managing the disorder, making this a vital reference for medical specialists and consultants in neurology and neuropharmacology and any clinician seeing patients on medications crossing the blood-brain barrier.
650		0	_aMovement disorders _xEtiology.
650		0	_aMovement disorders.
650		0	_aMovement disorders _xTreatment.
700	1		_aFriedman, Joseph H., _eeditor.
776	0	8	_iPrint version: _z9781107066007
856	4	0	_uhttps://doi.org/10.1017/CBO9781107588738
999			_c516101 _d516099